Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Wednesday, February 10, 2010, 6:14pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares,
Register
FINANCE HOME PAGE
INVESTING
FINANCE NEWS
Enter symbol(s):
Market:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
|
Alphabetical List
Amgen Inc. (AMGN)
At 5:00AM SGT:
57.21 USD
0.00 (0.00%)
MORE ON AMGN
Quotes
Summary
Options
Historical Prices
Charts
Basic Chart
Technical Chart
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
Amgen Inc.
(NasdaqNM:AMGN) Delayed quote data
Last Trade:
57.21 USD
Trade Time:
5:00AM SGT
Change:
0.00 (0.00%)
Prev Close:
57.21
Open:
N/A
Bid:
53.06
x 2000
Ask:
N/A
1y Target Est:
69.24
Day's Range:
N/A - N/A
52wk Range:
44.96 - 64.76
Volume:
0
Avg Vol
(3m)
:
6,527,030
Market Cap:
56.92B
P/E
(ttm)
:
12.48
EPS
(ttm)
:
4.59
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
max
Use Y! Toolbar to track stocks
Add AMGN to Portfolio
Download Data
HEADLINES
U.S. Stocks Gain on Hopes for Greece Aid
at The Wall Street Journal Online
(Wed 11:09am)
Amgen's denosumab offers hope in rare bone tumours
at Reuters
(Wed 8:01am)
Coca-Cola and industrials help stocks rally
at FT.com
(Wed 6:20am)
Amgen, Apple: Money Flow Leaders (AMGN, AAPL)
at The Wall Street Journal Online
(Wed 5:25am)
Dow Over 10,000; Greek Rescue Plan Pondered
at SmartMoney.com
(Wed 4:17am)
Don't Invest Another Penny
at Motley Fool
(Wed 1:41am)
Bone Up On This Potential Blockbuster
at Motley Fool
(Wed 12:58am)
Amgen sees positive data in bone drug study
AP
(Tue 11:58pm)
Positive Results on Amgen Drug
Zacks.com
(Tue 11:49pm)
Indications: U.S. futures recover after sub-10,000 Dow close
at MarketWatch
(Tue 9:59pm)
UPDATE - Amgen: denosumab prostate cancer trial meets goals
at Reuters
(Tue 8:39am)
More Headlines for AMGN...
ANALYST
EPS Est (next year)
(Dec-09)
:
5.00
EPS Est (in 2 years)
(Dec-10)
:
5.14
Avg Rec (current)*:
1.9
PEG Ratio:
1.33
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
Amgen Inc., a biotechnology company, engages in the discovery, development, manufacture, and marketing of human therapeutics based on advances in cellular and molecular biology.
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
Latest News
Singapore Indices